Condition: Non-Alcoholic Fatty Liver Disease · Sponsor: Yunnan Cancer Hospital
The purpose of this study is to quantitatively assess the changes in liver fat content in cancer patients before and after treatment. The main questions it aims to answer are:How does the liver fat fraction change before and after chemotherapy? In this study, patients undergoing mDixon Quant scanning are subjected to fully automated segmentation and measurement of liver fat content using artificial intelligence.
This description comes directly from the study's public registry record.
Lizhu Liu, Graduate · 18287509587 · liulizhu2022@163.com
Zhenhui Li, MD · 13698736132 · lizhenhui@kmmu.edu.cn
Always discuss trial participation with your own doctor first.
| Yunnan Cancer Hospital | Kunming, Yunnan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06735118